FAS and autoimmune lymphoproliferative syndrome: These cases were matched 2:1 by age (adult or pediatric), site, and type of genetic variant (death domain, extracellular or transmembrane domain; germline or somatic) with patients with CD4> 300 T-cells/μL and confirmed diagnosis of ALPS-FAS.